Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. The company is headquartered in Yantai, Shandong and currently employs 5,115 full-time employees. The company went IPO on 2014-07-09. The firm operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.
02186.HK stock price ended at $2.7 on 금요일, after rising 1.12%
On the latest trading day Feb 13, 2026, the stock price of 02186.HK rose by 1.12%, climbing from $2.67 to $2.70. Throughout the session, the stock experienced a volatility of 2.26%, with prices fluctuating between a daily low of $2.65 and a high of $2.71. Alongside this price increase, trading volume also rose by 4.0M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 11.4M shares were traded, amounting to a market value of approximately $10.7B.
02186.HK 기술적 시그널
기술적 시그널 요약
구매 신호 1
중립 신호 2
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02186.HK은 현재 1개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 1.12%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
02186.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 02186.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.